NDC 73648-155 - RYONCIL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73648-155
- Manufacturer
- Mesoblast | Mesoblast, Inc. | LONZA BIOLOGICS TUAS PTE. LTD. | Integrated Commercialization Solutions, LLC | WuXi Advanced Therapies Inc.
- Effective date
- 2025-09-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| RYONCIL | Mesoblast | Mesoblast, Inc. | LONZA BIOLOGICS TUAS PTE. LTD. | Integrated Commercialization Solutions, LLC | WuXi Advanced Therapies Inc. | 2025-09-11 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.